Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SENP3 | Q9H4L4 | 2/20 | 0.31 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.31 |
| ▸ | SENP1 | Q9P0U3 | 2/20 | 0.31 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.31 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11968681 | 0.76 | ALDH1A1 (0.31) | ALDH1A1HSD17B10 | |
| SCHEMBL12174816 | 0.71 | ALDH1A1 (0.36) | ALDH1A1HSD17B10 | |
| SCHEMBL667719 | 0.66 | ALDH1A1 (0.42) | ALDH1A1HSD17B10 | |
| SCHEMBL28162127 | 0.65 | RAD1 (0.37) | ALDH1A1HSD17B10SENP3SENP2SENP1 | |
| SCHEMBL18268213 | 0.65 | ALDH1A1 (0.54) | ALDH1A1HSD17B10 | |
| SCHEMBL3089972 | 0.65 | LCK (0.43) | ALDH1A1HSD17B10SENP3SENP2SENP1 | |
| SCHEMBL13214341 | 0.64 | CASP6 (0.50) | ALDH1A1HSD17B10SENP2SUMO2SUMO1 | |
| SCHEMBL8817406 | 0.64 | SENP2 (0.43) | ALDH1A1HSD17B10SENP3SENP2SENP1 | |
| SCHEMBL19511694 | 0.64 | PTK2 (0.30) | — | |
| SCHEMBL17878197 | 0.63 | ALDH1A1 (0.48) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170120163-A1 | SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES | PENTRACOR GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170120163-A1 | SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES | CHKA, PHOSPHO1, C3AR1 | ALDH1A1 4540/4885HSD17B10 3435/4885SENP3 1303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.